QuidelOrtho has a total of 2220 patents globally, out of which 1320 have been granted. Of these 2220 patents, more than 32% patents are active. United States of America is where QuidelOrtho has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of QuidelOrtho.
QuidelOrtho was founded in the year 1979. The Company provides health care services. The Company offers technologies and platforms to benefit customers with expanded access to clinical chemistry, immunoassay, molecular diagnostics, immunohematology, donor screening and point-of-care diagnostics offerings. As of April 2023, the market cap of QuidelOrtho is $6.27 Billion.
Do read about some of the most popular patents of QuidelOrtho which have been covered by us in this article and also you can find QuidelOrtho patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over QuidelOrtho patent portfolio.
How many patents does the founder and the CEO of QuidelOrtho have?
The founders David Katz has 47 patents and Scott Glenn has 44 patents. The CEO Douglas C. Bryant has 0 patent.
How many patents does QuidelOrtho have?
QuidelOrtho has a total of 2220 patents globally. These patents belong to 543 unique patent families. Out of 2220 patents, 720 patents are active.
How Many Patents did QuidelOrtho File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||QuidelOrtho Applications Filed||QuidelOrtho Patents Granted|
How many QuidelOrtho patents are Alive/Dead?
How Many Patents did QuidelOrtho File in Different Countries?
Countries in which QuidelOrtho Filed Patents
|United States Of America||385|
|Hong Kong (S.A.R.)||28|
Where are Research Centres of QuidelOrtho Patents Located?
10 Best QuidelOrtho Patents
US7282328B2 is the most popular patent in the QuidelOrtho portfolio. It has received 319 citations so far from companies like Asm Scientific, TwistDix and Monsanto Technology.
Below is the list of 10 most cited patents of QuidelOrtho:
|Publication Number||Citation Count|
How many inventions of other companies were rejected due to QuidelOrtho patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to QuidelOrtho invention. They couldn’t because QuidelOrtho had protected those before them.
Examiners at the USPTO referred 128 QuidelOrtho patents in 687 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the QuidelOrtho patent portfolio are Barclays Bank, Siemens Healthcare Diagnostics and Alere.
List of the Companies whose Patents were rejected citing QuidelOrtho –
|Company||Number of Patent Applications that faced Rejection Citing QuidelOrtho Patents||Number of Rejections (102 & 103)|
|Siemens Healthcare Diagnostics||13||29|
|Bank Of America||7||19|
|Reliant Immune Diagnostics||6||23|
|Lumos Diagnostics Holdings||6||18|
|Ortho Clinical Diagnostics||4||10|
|Critical Care Diagnostics||3||5|
|Hc Innovative Partners||3||6|
Count of 102 and 103 Type Rejections based on QuidelOrtho Patents
Top QuidelOrtho Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of QuidelOrtho US Patent Applications were Granted?
QuidelOrtho (Excluding its subsidiaries) has filed 333 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 268 have been granted leading to a grant rate of 90.85%.
Below are the key stats of QuidelOrtho patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for QuidelOrtho?
|Law Firm||Total Applications||Success Rate|
|Mcdermott Will & Emery||109||88.64%|
|Medlen & Carroll||34||90.91%|
|Kilpatrick Townsend & Stockton||7||83.33%|
|Ortho Clinical Diagnostics||5||100.00%|
|King & Spalding||4||25.00%|
|Morrison & Foerster||4||66.67%|